Welltower Inc. (W1EL34)
Sao Paulo Exchange · Brazil · prices in BRL · close of 20 Oct 2026
Key indicators
| Last close | BRL 74.62 |
|---|---|
| 52-week range | 53.93 – 620.00 |
| Return, 1 month / 3 months | +0.8% / −2.4% |
| Return, 1 year / 3 years | +37.1% / +304.9% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 49 |
| Volatility (1 year) | 418.0% |
| Worst drawdown (1 year) | -88.8% |
| Average daily value traded | 0.04M BRL |
| Dividend yield | 57.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Welltower Inc. is a real estate investment trust that invests in healthcare infrastructure. It owns and operates senior housing communities, post-acute care facilities and medical office buildings, leasing space to care providers and health systems. Its customers are operators of senior living and healthcare services, mainly in the United States and other developed markets. The company is based in Toledo, Ohio, and its properties serve older people and patients who need ongoing care and medical services.
Welltower Inc. is represented on the Sao Paulo Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code W1EL34, with its price quoted in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Welltower Inc. (W1EL34) trades on the Sao Paulo Exchange in Brazil. It last closed at BRL 74.62 on 20 October 2026.
Its price-based Market X-Ray is 47 out of 100 (a weak price profile), ranking 871 of 1,454 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 37.1% and over the last three months it fell 2.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Sao Paulo Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 50 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 1.9% | ||
| From 52-week high | -88.0% | ||
| Momentum | 69 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -2.4% | ||
| 6-month return | 25.0% | ||
| 12-month return, skipping the last month | 36.0% | ||
| Stability (higher is calmer) | 3 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 418.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -88.8% | ||
| Liquidity | 51 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.04M BRL | ||
| Zero-volume days | 18.3% | ||
| Income | 85 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 57.7% | ||
| Years with dividends | 6 |
Strengths
- Income: Dividend is high and has been paid regularly.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +2.9% |
|---|---|
| 1 month | +0.8% |
| 3 months | −2.4% |
| 6 months | +25.0% |
| 1 year | +37.1% |
| 3 years | +304.9% |
| 5 years | – |
Signals
| 50-day / 200-day average | 96.36 / 73.20 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 7.58 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 10 Aug 2026 | USD 11.8715 |
| 11 May 2026 | USD 10.0378 |
| 23 Feb 2026 | USD 10.3294 |
| 7 Nov 2025 | USD 10.7911 |
| 8 Aug 2025 | USD 10.8892 |
| 12 May 2025 | USD 10.2483 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Sao Paulo Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.